Alanine scanning of LL-37 revealed that antimicrobial activity and inflammatory signaling are controlled by different amino acids on the peptide's helix — the hydrophobic face drives inflammation through scavenger receptor binding, while other positions control bacterial killing.
Functions are separableMutating the hydrophobic face of LL-37 eliminated inflammatory signaling while preserving or even improving antimicrobial activity — a key insight for designing safer peptide antibiotics
What the researchers found
Alanine scanning revealed: some substitutions increased antimicrobial activity, while hydrophobic face substitutions (F5A, I24A, L31A) inhibited scavenger receptor binding and inflammatory response without disrupting RNA organization. LL-37 functions as an "innate immune vetter" via SR-B1 binding.
Why it matters
Separating LL-37's antimicrobial and inflammatory functions is crucial for designing therapeutic peptides that kill bacteria without triggering harmful inflammation — relevant to conditions like psoriasis where LL-37-driven inflammation causes disease.
The numbers in context
Hydrophobic face mutations abolished SR-B1 binding; maintained 3.5 nm inter-RNA spacing; some variants had enhanced antimicrobial activity
How the study worked
Structure-function study. Alanine scanning of LL-34. Antimicrobial testing against S. aureus and GAS. Type 1 interferon induction with U1 RNA. SR-B1 binding on keratinocytes. Small-angle X-ray scattering (SAXS) of peptide-RNA complexes.
Who was studied
Keratinocyte and endothelial cell lines; S. aureus and GAS bacteria
What this study cannot tell us
Alanine scanning of LL-34 (slightly shorter than LL-37). In vitro studies with specific RNA (U1) and cell types. In vivo relevance of structural findings needs confirmation. Disease-context effects on LL-37 structure not addressed.
How to read the evidence
Moderate evidence: thorough structure-function analysis using multiple methods (mutagenesis, SAXS, cellular assays). In vitro study with clear mechanistic insights.
When this study was published
Published 2021. LL-37 structure-function research continues informing antimicrobial peptide drug design and understanding of inflammatory skin diseases.
The bigger picture
LL-37 is implicated in autoimmune conditions like psoriasis, rosacea, and lupus where it triggers inappropriate inflammation. Understanding exactly which structural features drive inflammation versus microbial killing enables design of safer LL-37-based antimicrobials.
Questions still open
- Could LL-37 variants with enhanced antimicrobial but reduced inflammatory activity treat infections in inflammatory skin diseases?
- Does the innate immune vetting mechanism apply to other cathelicidins in different species?
- Would blocking LL-37's SR-B1 binding reduce inflammation in psoriasis without impairing antimicrobial defense?
Common questions
Why does LL-37 cause inflammation?
Could better-designed LL-37 treat infections without inflammation?
Read the original research
Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors.
The Journal of biological chemistry, 297(1), 100828
Citation
Kulkarni, Nikhil N; O'Neill, Alan M; Dokoshi, Tatsuya; Luo, Elizabeth W C; Wong, Gerard C L; Gallo, Richard L. (2021). Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors.. The Journal of biological chemistry, 297(1), 100828. https://doi.org/10.1016/j.jbc.2021.100828